APA (7th ed.) Citation

Yan, X., Price, G., Raynes, G., Stares, M., Evans, T., Campbell, S., . . . Phillips, I. (2022). 70 - Adjuvant durvalumab post-chemoradiotherapy in stage III non-small cell lung cancer: Experience from the Edinburgh Cancer Centre. Lung Cancer (01695002), 165, S34. https://doi.org/10.1016/S0169-5002(22)00117-9

Chicago Style (17th ed.) Citation

Yan, Xiangfei, et al. "70 - Adjuvant Durvalumab Post-chemoradiotherapy in Stage III Non-small Cell Lung Cancer: Experience from the Edinburgh Cancer Centre." Lung Cancer (01695002) 165 (2022): S34. https://doi.org/10.1016/S0169-5002(22)00117-9.

MLA (9th ed.) Citation

Yan, Xiangfei, et al. "70 - Adjuvant Durvalumab Post-chemoradiotherapy in Stage III Non-small Cell Lung Cancer: Experience from the Edinburgh Cancer Centre." Lung Cancer (01695002), vol. 165, 2022, p. S34, https://doi.org/10.1016/S0169-5002(22)00117-9.